Highlights from the European Cancer Congress (ECCO/ESMO/ESTRO) and the Canadian Association of Genitourinary Medical Oncologists (CAGMO) meeting
REPORTS FROM ECC
assessing the benefits of new treatments for crpc
updates on major trials
does somatostatin have a role in treatment?
Report from cagmo
is pazopanib the preferred first-line treatment for metastatic renal cell carcinoma?